|
Volumn 58, Issue 3, 2002, Pages 560-568
|
Adaptive decision making in a lymphocyte infusion trial
|
Author keywords
Adaptive randomization; Bayesian design; Dose finding; Leukemia; Lymphocyte infusion
|
Indexed keywords
BLOOD;
CYTOLOGY;
DECISION MAKING;
DISEASES;
LYMPHOCYTES;
MOLECULAR BIOLOGY;
TOXICITY;
ADAPTIVE DECISION MAKING;
ADAPTIVE RANDOMIZATION;
BAYESIAN DESIGN;
CELL COUNT;
CLINICAL TRIAL;
DOSE FINDING;
LEUKEMIA;
LYMPHOCYTE INFUSION;
RANDOMISATION;
WHITE BLOOD CELLS;
RANDOM PROCESSES;
GEMTUZUMAB OZOGAMICIN;
STEROID;
DISEASE;
ALGORITHM;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ARTICLE;
BAYES THEOREM;
CANCER IMMUNOTHERAPY;
CELL RENEWAL;
CHILL;
CLINICAL TRIAL;
DATA ANALYSIS;
DECISION MAKING;
DOSE CALCULATION;
FEVER;
HEMATOLOGIC DISEASE;
HUMAN;
LEUKOCYTE COUNT;
LEUKOPENIA;
LIVER TOXICITY;
LYMPHOCYTE TRANSFER;
PARAMETRIC TEST;
PROBABILITY;
RANDOMIZATION;
RECURRENT DISEASE;
SIMULATION;
STATISTICAL ANALYSIS;
STATISTICAL MODEL;
SURVIVAL TIME;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
EID: 0036714091
PISSN: 0006341X
EISSN: None
Source Type: Journal
DOI: 10.1111/j.0006-341X.2002.00560.x Document Type: Article |
Times cited : (27)
|
References (17)
|